Kristen Harrington-Smith
CIK 1894310 · SVP & CHIEF COMMERCIAL OFFICER · last filed 2024-06-13
Kristen Harrington-Smith is a SVP & CHIEF COMMERCIAL OFFICER who has filed 8 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for EFTRW, was dated Jun 13, 2024.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
8
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | Director | — | $0.00 | — | $0 | 6 | 2024-06-13 |
| ImmunoGen, Inc. (IMGN) Delisted | SVP & CHIEF COMMERCIAL OFFICER | 25,000 | $31.23 | $780.8K | $0 | 2 | 2022-11-18 |
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-13 | eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-02-21 | eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-22 | eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-01-24 | eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-11-18 | ImmunoGen, Inc. (IMGN) Delisted | Exer (M) | +25,000 | $0 | EDGAR |
| 2022-06-13 | eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-02-17 | eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-11-17 | ImmunoGen, Inc. (IMGN) Delisted | Grant (A) | — | $0 | EDGAR |